Dyne Therapeutics has a total of 690 patents globally, out of which 82 have been granted. Of these 690 patents, more than 83% patents are active. United States of America is where Dyne Therapeutics has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Dyne Therapeutics.
Dyne Therapeutics founded in 2018, Dyne Therapeutics is a biotechnology company developing targeted therapies for genetically driven neuromuscular diseases. Its pipeline focuses on conditions such as Duchenne muscular dystrophy and myotonic dystrophy, aiming to address root causes by targeting muscle and the central nervous system.
Do read about some of the most popular patents of Dyne Therapeutics which have been covered by us in this article and also you can find Dyne Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Dyne Therapeutics patent portfolio.
How many patents does Dyne Therapeutics have?
Dyne Therapeutics has a total of 690 patents globally. These patents belong to 48 unique patent families. Out of 690 patents, 583 patents are active.
How Many Patents did Dyne Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Dyne Therapeutics Applications Filed | Dyne Therapeutics Patents Granted |
| 2026 | 1 | 13 |
| 2025 | 41 | 31 |
| 2024 | 78 | 16 |
| 2023 | 111 | 14 |
| 2022 | 161 | 6 |
| 2021 | 195 | 2 |
| 2020 | 9 | – |
| 2019 | 94 | – |
How many Dyne Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Dyne Therapeutics File in Different Countries?
Countries in which Dyne Therapeutics Filed Patents
| Country | Patents |
| United States of America | 107 |
| Japan | 50 |
| Europe (EPO) | 49 |
| Singapore | 47 |
| China | 46 |
| Canada | 42 |
| Israel | 39 |
| Korea (South) | 37 |
| Eurasia | 35 |
| South Africa | 34 |
| Australia | 30 |
| India | 29 |
| Hong Kong (S.A.R.) | 28 |
| Mexico | 27 |
| Brazil | 22 |
| New Zealand | 6 |
| Macao | 1 |
Where are Research Centres of Dyne Therapeutics Patents Located?
The Research Centre for all the Dyne Therapeutics patents is the United States of America.
10 Best Dyne Therapeutics Patents
WO2020028832A1 is the most popular patent in the Dyne Therapeutics portfolio. It has received 110 citations so far from companies like Sarepta Therapeutics Inc, PeptiDream Inc and Biogen Ma Inc.
Below is the list of 10 most cited patents of Dyne Therapeutics:
| Publication Number | Citation Count |
| WO2020028832A1 | 110 |
| WO2020028857A1 | 89 |
| WO2020028861A1 | 84 |
| WO2020028836A1 | 78 |
| WO2021142313A1 | 77 |
| WO2020028842A1 | 69 |
| WO2021142307A1 | 68 |
| US11286305B2 | 67 |
| US11111309B2 | 67 |
| WO2020028841A1 | 67 |
What Percentage of Dyne Therapeutics US Patent Applications were Granted?
Dyne Therapeutics (Excluding its subsidiaries) has filed 84 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 34 have been granted leading to a grant rate of 73.91%.
Below are the key stats of Dyne Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Dyne Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Dyne Therapeutics (Inhouse IP Dept.) | 84 | 73.91% |
What are Dyne Therapeutics key innovation segments?
What Technologies are Covered by Dyne Therapeutics?
The chart below distributes patents filed by Dyne Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Dyne Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Dyne Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Dyne Therapeutics?
